- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06145646
Intramuscular Temperature on the Echo-textural Characteristics
Influence of Intramuscular Temperature on the Textural Characteristics of the B-mode Ultrasound Image.
Echointensity and echotexture have been used as a physiological marker for changes in skeletal muscle quality and structure caused by physical training, low activity, ageing and some neuromuscular disorders. However, there are some influencing factors on muscle echo-intensity and echotexture, such as temperature, which may not be taken into account when performing an ultrasound assessment and may alter the results.
This study aims to investigate the effects of muscle temperature on echointensity and other 2nd order echotextures variables such as homogeneity, contrast, correlation and entropy of muscle tissue, in order to gain a better understanding of this correlation and minimise its influence, which would allow greater precision in the use of muscle ultrasound as a diagnostic tool.
The methodology of this study includes firstly the acquisition of ultrasound images of the vastus lateralis muscle. This acquisition will be performed during the continuous recording of muscle temperature, carried out during a passive cooling process after 20 min of heating using microwave equipment. In addition, to standardise the results, a correction factor will be calculated to compensate for the influence of subcutaneous adipose tissue thickness on echogenicity and echotexture.
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sergio Montero-Navarro, PhD
- Phone Number: 67704 965426486
- Email: sergio.montero@uchceu.es
Study Contact Backup
- Name: Javier Molina-Payá, PhD
- Phone Number: 67804 965426486
- Email: francisco.molina@uchceu.es
Study Locations
-
-
Alicante
-
Elche, Alicante, Spain, 03203
- Recruiting
- Sergio Montero Navarro
-
Contact:
- SERGIO MONTERO NAVARRO, PhD
- Phone Number: 651472265
- Email: sergio.montero@uchceu.es
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Acceptance of participation in the study.
- Healthy subjects.
- Subjects between the ages of 18 and 65.
Exclusion Criteria:
- Have known neurological, cardiovascular, metabolic or orthopedic conditions that prevent them from participating in the study.
- Present metal implants in the heating area.
- Wear a pacemaker.
- Perform physical activity during the 48 hours prior to data collection.
- Contraindications of dry needling such as: Belonephobia, history of abnormal reaction to the puncture or injection, anticoagulant treatment or thrombocytopenia, lymphedema over the area of intervention, severely compromised immune system, vascular diseases, diabetes mellitus, pregnancy, epilepsy, allergy to metals or that the intervention area has wounds, scars, tattoos, or stains.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Muscle temperature
Heating the vastus lateralis of the right quadriceps using microwaves
|
Passive heating of the vastus lateralis of the right quadriceps will be performed using a microwave device.
The device will be set at a power of 150 W and a distance of 10-15 cm from the skin surface for 20 minutes with the purpose of increasing local muscle temperature to 40 ºC.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle echointensity (0-255 a.u.).
Time Frame: During intervention
|
Muscle echointensity is calculated by the mean gray level value of the muscle Range of Interest (ROI).
(0-255 a.u.)
|
During intervention
|
Muscle echovariance (0-255 a.u.).
Time Frame: During intervention
|
The echovariance is determined by the relationship between the standard deviation and the average pixel intensity obtained from the histogram of the muscle ROI.
(0-255 a.u.)
|
During intervention
|
Muscle energy or second angular momentum.
Time Frame: During intervention
|
It is a second order parameter (GLCM) that measures textural uniformity of the muscle ROI
|
During intervention
|
Muscle homogeneity.
Time Frame: During intervention
|
It is a second-order parameter (GLCM) that measures the uniformity of the muscle ROI composition.
|
During intervention
|
Contrast.
Time Frame: During intervention
|
It is a second-order parameter (GLCM) that measures local variations in gray levels of the muscle ROI.
|
During intervention
|
Textural Correlation.
Time Frame: During intervention
|
It is a second-order parameter (GLCM) that expresses linear gray-level dependencies of the muscle ROI.
|
During intervention
|
Entropy.
Time Frame: During intervention
|
It is a second-order parameter (GLCM) to measure muscle ROI disorder.
|
During intervention
|
Echointensity correction factor for adipose thickness
Time Frame: Pre-intervention
|
The measurement of subcutaneous adipose thickness will be carried out through the average of the distance from the skin to the aponeurosis coinciding with the superficial interface of the muscle and with different pressures of the probe on the skin.
This measure will be used to develop a correction factor that allows compensating the influence of this variable on echogenicity and echotexture, standardizing the results.
|
Pre-intervention
|
Muscle temperature (ºC).
Time Frame: Pre-intervention and during intervention
|
Measurement of intramuscular temperature of the right vastus lateralis of the quadriceps (ºC)
|
Pre-intervention and during intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age (years)
Time Frame: Pre-intervention
|
Subject's age (years)
|
Pre-intervention
|
Sex (female or male)
Time Frame: Pre-intervention
|
Subject's sex (female or male)
|
Pre-intervention
|
Dominance
Time Frame: Pre-intervention
|
Dominant leg (right-left)
|
Pre-intervention
|
Body mass index
Time Frame: Pre-intervention
|
It is a measure of body fat based on height and weight that applies to adult men and women
|
Pre-intervention
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Pillen S, Tak RO, Zwarts MJ, Lammens MM, Verrijp KN, Arts IM, van der Laak JA, Hoogerbrugge PM, van Engelen BG, Verrips A. Skeletal muscle ultrasound: correlation between fibrous tissue and echo intensity. Ultrasound Med Biol. 2009 Mar;35(3):443-6. doi: 10.1016/j.ultrasmedbio.2008.09.016. Epub 2008 Dec 10.
- Akima H, Yoshiko A, Tomita A, Ando R, Saito A, Ogawa M, Kondo S, Tanaka NI. Relationship between quadriceps echo intensity and functional and morphological characteristics in older men and women. Arch Gerontol Geriatr. 2017 May-Jun;70:105-111. doi: 10.1016/j.archger.2017.01.014. Epub 2017 Jan 20.
- Young HJ, Jenkins NT, Zhao Q, Mccully KK. Measurement of intramuscular fat by muscle echo intensity. Muscle Nerve. 2015 Dec;52(6):963-71. doi: 10.1002/mus.24656. Epub 2015 Sep 7.
- Teixeira CA, Alvarenga AV, Cortela G, von Kruger MA, Pereira WC. Feasibility of non-invasive temperature estimation by the assessment of the average gray-level content of B-mode images. Ultrasonics. 2014 Aug;54(6):1692-702. doi: 10.1016/j.ultras.2014.02.021. Epub 2014 Mar 1.
- Pinto MD, Silveira Pinto R, Nosaka K, Blazevich AJ. Do Intramuscular Temperature and Fascicle Angle Affect Ultrasound Echo Intensity Values? Med Sci Sports Exerc. 2023 Apr 1;55(4):740-750. doi: 10.1249/MSS.0000000000003082. Epub 2022 Nov 8.
- Kenny GP, Reardon FD, Zaleski W, Reardon ML, Haman F, Ducharme MB. Muscle temperature transients before, during, and after exercise measured using an intramuscular multisensor probe. J Appl Physiol (1985). 2003 Jun;94(6):2350-7. doi: 10.1152/japplphysiol.01107.2002. Epub 2003 Feb 21.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CEEI23_453
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Access to identified personal information will be restricted to the principal investigator of the study/collaborators, the Research Ethics Committee and authorized personnel, when necessary to verify the data and procedures of the study, but always maintaining their confidentiality in accordance to current legislation.
The personal data of the participants, obtained during their participation in the project, will be kept for the time necessary for the development of this research, which is estimated to be 6 months, and will subsequently be destroyed, and cannot be kept without having previously been anonymized.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
Lund UniversityCompletedHealthy Subjects | Diet, HealthySweden
-
PfizerRecruitingHealthy Subjects | Healthy ParticipantsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Healthy Subjects | ImmunosuppressionUnited States
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
NeuShen TherapeuticsNot yet recruiting
-
GEN İlaç ve Sağlık Ürünleri A.Ş.Sulfateq B.V.Recruiting
-
Bio-innova Co., LtdNot yet recruiting
-
Bio-innova Co., LtdNot yet recruiting
Clinical Trials on Muscle warm-up
-
Federal University of BahiaBahia State Secretariat of Education, BrazilCompleted
-
Opti'MouvUniversité Grenoble-AlpesCompleted
-
Riphah International UniversityCompletedSports Physical TherapyPakistan
-
University of PortsmouthTerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Universidade Federal do Rio Grande do NorteCompletedNeuromuscular Manifestations
-
University of Erlangen-NürnbergCompletedPostural BalanceGermany
-
Dokuz Eylul UniversityCompletedChronic Obstructive Pulmonary Disease | COPDTurkey
-
University of the State of Santa CatarinaCompletedHip Adduction | Gluteus EMG ActivityBrazil
-
Paulista UniversityRecruiting
-
University of ExtremaduraLuis Espejo AntúnezCompleted